Scientists map Body's defense after RSV shot
NCT ID NCT07185399
Summary
This study aims to understand how the immune systems of adults aged 60 and older respond to the FDA-approved Moderna RSV vaccine. Researchers will collect detailed biological data from 14 participants to identify early signs of a strong immune response and learn how long protection might last. The goal is to gather knowledge about how this specific mRNA vaccine works, not to test if it is safe or effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.